Trading IP Could Change Ideas On Value, Access For Drugs, Devices
This article was originally published in PharmAsia News
Executive Summary
Profiting on a potential drug discovery or medical device may mean giving up a substantial portion of intellectual property rights in order to draw in the talent needed for commercialization.